#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage I Cholangiocarcinoma Polycystic liver disease Acromegaly Neoplasm malignant Wiskott-Aldrich syndrome Ovarian cancer stage III Hyperchylomicronaemia Hyperoxaluria Peritoneal mesothelioma malignant Hereditary angioedema Neurodevelopmental disorder Breast angiosarcoma Arrhythmia Head and neck cancer More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Diagnostics Pulmonary fibrosis – Life with Disease Haemophilia – Basic Information Immunodeficiency congenital – Basic Information Piriformis syndrome – Diagnostics Acquired haemophilia – Diagnostics Richter’s syndrome – Treatment Hairy cell leukaemia – Trials in Disease Rosai-Dorfman syndrome – Basic Information Hairy cell leukaemia recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abelacimab Fianlimab Tiotropium Bromide Monohydrate Regadenoson HYDROMORPHONE HYDROCHLORIDE Protrans Raxtozinameran Sodium Picosulfate Pertechnetate (99Mtc) Sodium Pyridoxine Tenofovir Disoproxil Riluzole Doxribtimine Daridorexant Gsk3915393 Epinephrine Linaclotide Regn9933 Mifepristone Rbd5044 Sodium More therapies…

    Learn about Your Condition

    Major depression Skin wrinkling Short stature Tricuspid valve disease Cardiac ventricular thrombosis Antisynthetase syndrome Hypoaesthesia Macular degeneration Lumbosacral radiculopathy Hypotonia Hepatic adenoma Urticaria chronic Renal cell carcinoma stage IV Oral lichen planus Rhabdomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dermatomyositis

  • Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Effects of Enpatoran for Patients with Dermatomyositis and Polymyositis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Enpatoran
    Czechia Greece Italy Poland Spain Sweden

  • Study on the Effects of GLPG3667 for Adults with Dermatomyositis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatomyositis
    Investigated Drugs:
    • Glpg3667 Fumarate
    Belgium Bulgaria Croatia Czechia France Germany +4
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!